Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
7,700
Stocks News & Analysis
stocks
PayPal earnings: Growth slows, new CEO appointed
stocks
Morningstar initiates on ASX income play
stocks
What Goodman’s upcoming earnings could reveal about data centre & AI growth
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,185.70 | 37.60 | 0.41% |
| CAC 40 | 8,179.50 | 1.67 | -0.02% |
| DAX 40 | 24,780.79 | 16.73 | -0.07% |
| Dow JONES (US) | 49,240.99 | 166.67 | -0.34% |
| FTSE 100 | 10,314.59 | 26.97 | -0.26% |
| HKSE | 26,812.02 | 22.75 | -0.08% |
| NASDAQ | 23,255.19 | 336.92 | -1.43% |
| Nikkei 225 | 54,424.75 | 295.91 | -0.54% |
| NZX 50 Index | 13,406.68 | 14.84 | -0.11% |
| S&P 500 | 6,917.81 | 58.63 | -0.84% |
| S&P/ASX 200 | 8,905.40 | 53.10 | 0.60% |
| SSE Composite Index | 4,080.20 | 12.47 | 0.31% |